பீட்டர் ஆல்பர்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பீட்டர் ஆல்பர்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பீட்டர் ஆல்பர்ஸ் Today - Breaking & Trending Today

New Drug Combats Late-stage Prostate Cancer

New Drug Combats Late-stage Prostate Cancer
by Angela Mohan on
July 12, 2021 at 11:18 AM
New treatment combats late stage prostate cancer by delivering beta radiation directly to tumour cells. It is well tolerated by patients and keeps them alive for longer compared to standard care, as per the phase 3 trial findings.
New approach, targets a molecule called PSMA, which is known to be increased on the surfaces of the tumour cells, destroying them and their surrounding microenvironment.
International team of researchers set out to see whether Lu-PSMA-617 was more effective than standard care and recruited 831 patients with metastatic castration-resistant prostate cancer between June 2018 and October 2019. Patients were randomized to receive the treatment plus standard care or standard care alone. ....

Toxicityprostate Cancercancer , Factscancer Factscancertattoos , Peter Albers , Ken Herrmann , National Institute For Health , Scientific Office , Head Of The Department Urology , Dusseldorf University , Johann De Bono , National Institute , Care Excellence , Professor Peter Albers , Homeopathyclinical Trials , Trans Urethral Resection , பீட்டர் ஆல்பர்ஸ் , கேன் ஹெர்மன் , தேசிய நிறுவனம் க்கு ஆரோக்கியம் , அறிவியல் அலுவலகம் , தலை ஆஃப் தி துறை சிறுநீரகம் , ஜோஹான் டி போனோ , தேசிய நிறுவனம் , பராமரிப்பு சிறப்பானது ,

New Drug Targets Treatment-Resistant Prostate Cancers and Prolongs Trial Participants' Lives

New Drug Targets Treatment-Resistant Prostate Cancers and Prolongs Trial Participants' Lives
technologynetworks.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technologynetworks.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Peter Albers , Ken Herrmann , National Institute For Health , European Association Of Urology , Scientific Office , Institute Of Cancer Research , Head Of The Department Urology , Dusseldorf University , European Association , Johann De Bono , Experimental Cancer Medicine , Cancer Research , Consultant Medical Oncologist , Royal Marsden , Professor Ken Herrmann , Nuclear Medicine , University Hospital Essen , National Institute , Care Excellence , Professor Peter Albers , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , பீட்டர் ஆல்பர்ஸ் , கேன் ஹெர்மன் ,

Obesity Linked to Lower Death Risk in mCRPC - Renal and Urology News

Obesity Linked to Lower Death Risk in mCRPC - Renal and Urology News
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

Peter Albers , Giuseppe Ottone Cirulli , European Association Of Urology , Salute San Raffaele University , Scientific Congress Office , European Association , Vita Salute San Raffaele University , Congress Office , Shared Equal Access Regional Cancer Hospital , பீட்டர் ஆல்பர்ஸ் , ஐரோப்பிய சங்கம் ஆஃப் சிறுநீரகம் , வணக்கம் சான் ராப்பஆேழே பல்கலைக்கழகம் , ஐரோப்பிய சங்கம் , வீடா வணக்கம் சான் ராப்பஆேழே பல்கலைக்கழகம் , காங்கிரஸ் அலுவலகம் ,

Obesity increases survival in advanced prostate cancer

E-Mail
Obese patients with a form of advanced prostate cancer survive longer than overweight and normal weight patients, new research has found.
The study, presented today at the European Association of Urology congress, EAU21, followed more than 1500 patients over three years. Patients classed as obese - with a BMI over 30 - had a ten percent higher survival rate than thinner patients over 36 months.
Although obesity is usually associated with an increased risk of death from many cancers and some other chronic diseases, there is some evidence in a few cancers of a survival advantage for patients with high body mass index. This phenomenon is known as the obesity paradox . ....

Peter Albers , Nicola Fossati , Alberto Martini , European Association Of Urology , San Raffaele University , Scientific Congress Office , European Association , Congress Office , பீட்டர் ஆல்பர்ஸ் , ஆல்பர்டோ மார்டினி , ஐரோப்பிய சங்கம் ஆஃப் சிறுநீரகம் , சான் ராப்பஆேழே பல்கலைக்கழகம் , ஐரோப்பிய சங்கம் , காங்கிரஸ் அலுவலகம் ,

New concept drug hunts down late-stage prostate cancer

E-Mail
A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumour cells, is well tolerated by patients and keeps them alive for longer than standard care, found a phase 3 trial to be presented at the European Association of Urology congress, EAU21, today.
Despite progress in medicine in recent years, metastatic castration-resistant prostate cancer remains untreatable and fatal. The new treatment, known as Lu-PSMA-617, takes a new approach, targeting a molecule called PSMA, which is known to be increased on the surfaces of the tumour cells, destroying them and their surrounding microenvironment. ....

City Of , United Kingdom , Peter Albers , Ken Herrmann , National Institute For Health , European Association Of Urology , Scientific Office , Institute Of Cancer Research , Head Of The Department Urology , Dusseldorf University , European Association , Johann De Bono , Experimental Cancer Medicine , Cancer Research , Consultant Medical Oncologist , Royal Marsden , Professor Ken Herrmann , Nuclear Medicine , University Hospital Essen , National Institute , Care Excellence , Professor Peter Albers , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , பீட்டர் ஆல்பர்ஸ் , கேன் ஹெர்மன் ,